The FOXP1 gene, which is involved in repressing pro-apoptotic genes, has been reported to be silenced in kidney and colon cancers, while its high expression has been associated with better prognosis in breast and lung cancers, aligning with these findings [67,68,69,70]. This evidence concerns the gene FOXP1 and lung cancer.